Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Evolent Health, Inc. EVH
$35.06
-$0.47 (-1.34%)
На 18:00, 12 мая 2023
+35.48%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
3983940480.00000000
-
week52high
39.78
-
week52low
21.83
-
Revenue
1352013000
-
P/E TTM
-181
-
Beta
1.54429000
-
EPS
-0.19000000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 июл 2023 г. в 10:59
Описание компании
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| JP Morgan | Overweight | Overweight | 19 авг 2022 г. |
| RBC Capital | Outperform | Outperform | 03 авг 2022 г. |
| Piper Sandler | Overweight | Overweight | 03 авг 2022 г. |
| BTIG | Buy | Buy | 03 авг 2022 г. |
| RBC Capital | Outperform | 29 июл 2022 г. | |
| Canaccord Genuity | Buy | Buy | 12 окт 2022 г. |
| BTIG | Buy | Buy | 12 окт 2022 г. |
| Piper Sandler | Overweight | Overweight | 04 ноя 2022 г. |
| Truist Securities | Hold | 01 ноя 2022 г. | |
| Cowen & Co. | Outperform | Outperform | 18 ноя 2022 г. |
| Cowen & Co. | Outperform | Outperform | 30 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| WILLIAMS FRANK J | D | 9060 | 110000 | 01 февр 2023 г. |
| WILLIAMS FRANK J | D | 626479 | 1500 | 01 февр 2023 г. |
| WILLIAMS FRANK J | D | 627979 | 108500 | 01 февр 2023 г. |
| WILLIAMS FRANK J | A | 736479 | 110000 | 01 февр 2023 г. |
| WILLIAMS FRANK J | D | 119060 | 110000 | 03 янв 2023 г. |
| WILLIAMS FRANK J | D | 626479 | 3292 | 03 янв 2023 г. |
| WILLIAMS FRANK J | D | 629771 | 106708 | 03 янв 2023 г. |
| WILLIAMS FRANK J | A | 736479 | 110000 | 03 янв 2023 г. |
| WILLIAMS FRANK J | D | 229060 | 110000 | 01 дек 2022 г. |
| WILLIAMS FRANK J | D | 626479 | 900 | 01 дек 2022 г. |
Новостная лента
Evolent Health, Inc. (EVH) Q1 2023 Earnings Call Transcript
Seeking Alpha
03 мая 2023 г. в 22:50
Evolent Health, Inc. (NYSE:EVH ) Q1 2023 Results Conference Call May 3, 2023 5:00 PM ET Company Participants Seth Frank - VP, IR Seth Blackley - CEO John Johnson - CFO Conference Call Participants Sandy Draper - Guggenheim Partners Anne Samuel - JP Morgan Charles Rhyee - TD Cowen David Larsen - BTIG Jailendra Singh - Truist Jeff Garro - Stephens Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity Ryan Daniels - William Blair Sean Dodge - RBC Capital Markets Operator Welcome to Evolent Health's Earnings Conference Call for the Quarter Ended March 31, 2023. As a reminder, this conference call is being recorded.
Evolent Health (EVH) Beats Q1 Earnings Estimates
Zacks Investment Research
03 мая 2023 г. в 20:32
Evolent Health (EVH) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.12 per share a year ago.
Fast Pitch: Essex Investments's co-CEO sees growth in this health care name
CNBC Television
20 апр 2023 г. в 19:19
Nancy Prial, Essex Investments Management co-chief executive officer & senior portfolio manager, on Evolent Health with CNBC's Melissa Lee and the Fast Money traders.
Evolent Health to Participate in Upcoming Conferences
PRNewsWire
03 мар 2023 г. в 08:00
WASHINGTON , March 3, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Financial Officer John Johnson and Vice President, Investor Relations, Seth Frank will participate in upcoming investor conferences, including meetings with institutional investors and presentations. A live audio-only webcast and replay for these events will be available on the investor relations section of Evolent's website at ir.evolenthealth.com/, unless otherwise noted below.
Evolent Health, Inc. (EVH) Q4 2022 Earnings Call Transcript
Seeking Alpha
22 февр 2023 г. в 23:29
Evolent Health, Inc. (NYSE:EVH ) Q4 2022 Earnings Conference Call February 22, 2023 5:00 PM ET Company Participants Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference Call Participants Sean Dodge - RBC Capital Markets Anne Samuel - JPMorgan Ryan Daniels - William Blair David Larsen - BTIG Sandy Draper - Guggenheim Richard Close - Canaccord Genuity Jailendra Singh - Truist Jessica Tassan - Piper Sandler Charles Rhyee - Cowen Operator Welcome to Evolent Health's Earnings Conference Call for the Fourth Quarter and Year ended December 31, 2022. As a reminder, this conference call is being recorded.